Skip to content
  • How big pharma could lose the war on disease

    Bloomberg - 12/02/2015

    Biologist Kim Lewis of Northeastern University, who has studied antibiotic development, sees the primary problem as the lack of any method for finding promising compounds. All the amazing progress a half century ago came when U.S. biochemist Selman Waksman developed a technique to systematically screen soil bacteria. This is how he discovered streptomycin, the first treatment for tuberculosis. After turning up other valuable drugs such as tetracycline, erythromycin and vancomycin, the technique eventually petered out. We still have nothing to replace it.

  • Cookies on Northeastern sites

    This website uses cookies and similar technologies to understand your use of our website and give you a better experience. By continuing to use the site or closing this banner without changing your cookie settings, you agree to our use of cookies and other technologies. To find out more about our use of cookies and how to change your settings, please go to our Privacy Statement.